CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.

about

Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospects.

P2860

Q55223567-F562A89E-DDC1-49D6-A4A5-F01BBDE039A4

P2860

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.

Item

http://www.wikidata.org/entity/Q49504289

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@en

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@nl

type

Item

label

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@en

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@nl

prefLabel

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@en

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@nl

P1476

CabaGast: multicentre, Phase I ...... ogastric junction and stomach.

@en

P2093

Alexander Reichart

http://www.w3.org/2001/XMLSchema#string

Alexander Schmittel

http://www.w3.org/2001/XMLSchema#string

Andreas Block

http://www.w3.org/2001/XMLSchema#string

Claudia Pauligk

http://www.w3.org/2001/XMLSchema#string

Claus Bolling

http://www.w3.org/2001/XMLSchema#string

Frank Kullmann

http://www.w3.org/2001/XMLSchema#string

Harald Schmalenberg

http://www.w3.org/2001/XMLSchema#string

Henning Eschenburg

http://www.w3.org/2001/XMLSchema#string

Lothar Müller

http://www.w3.org/2001/XMLSchema#string

Mathias Kleiß

http://www.w3.org/2001/XMLSchema#string

P2860

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLO

P2888

s00432-017-2565-5

P31

scholarly article

P356

10.1007/S00432-017-2565-5

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285668

http://www.w3.org/2001/XMLSchema#string

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.

about

P2860

P2860

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698